No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
SonoScape Medical Corp. is engaged in the global development and production of medical devices, originating from its base in China. Its comprehensive portfolio includes a diverse range of ultrasound diagnostic systems, encompassing cart-based color Doppler, handheld color Doppler, black and white ultrasound units, and specialized veterinary ultrasound apparatus. The company further provides endoscopy solutions, such as sophisticated image processing equipment, illumination tools, and products tailored for gastroenterological examinations. Beyond its hardware offerings, SonoScape extends crucial support services, including expert technical assistance, component provision, educational programs, system upgrades, and direct field intervention. Established in 2002, SonoScape Medical Corp. maintains its corporate headquarters in Shenzhen, China.
www.sonoscape.comNo one on the platform currently holds 300633.SZ.
No tracked institution reports a position in 300633.SZ as of their last filing.
No one on the platform has traded 300633.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.3% | 17.8% | — | — | — | |
| Rev. Growth % | 14.7% | 14.7% | ||||
| Profit Margin % | 8.5% | 15.0% | 13.7% | |||
| Free Cash Flow Margin % | -8.2% | 7.6% | 8.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2.6B | +17.4% | $0.67 | $0.65–$0.70 | — | 3 |
| 2027 | $3.0B | +13.8% | $0.92 | $0.92–$0.92 | — | 4 |
| 2028 | $3.4B | +14.4% | $1.14 | $0.91–$1.24 | — | 5 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-21 | $0.06 | $0.06 | +0.0% |
| 2026-04-29 | $0.13 | $-0.03 | -120.8% |
| 2026-04-17 | $0.38 | $0.38 | +0.0% |
| 2025-10-28 | $-0.03 | $-0.03 | +0.0% |
| 2025-08-21 | $0.09 | $0.09 | +0.0% |
| 2025-04-25 | $0.15 | $0.15 | +0.0% |
| 2025-04-12 | $0.09 | $0.07 | -25.7% |
| 2024-10-25 | $0.32 | $-0.14 | -143.8% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300633.SZSonoScape Medical Corp. | $18.52 | -0.70% | $7.9B | — |
| 300298.SZSinocare Inc. | $15.41 | -0.13% | $8.6B | — |
| 600055.SSBeijing Wandong Medical Technology Co., Ltd. | $10.10 | -0.30% | $7.1B | — |
| 600645.SSVcanbio Cell & Gene Engineering Corp., Ltd | $17.75 | -0.45% | $8.1B | — |
| 603883.SSLBX Pharmacy Chain Joint Stock Company |
| $12.65 |
| -1.25% |
| $9.6B |
| — |
| 688016.SSShanghai MicroPort Endovascular MedTech Co., Ltd. | $83.97 | +0.74% | $10.1B | — |
| 688050.SSEyebright Medical Technology (Beijing) Co., Ltd. | $37.61 | +0.97% | $7.3B | — |
Source: Financial Modeling Prep · peers by sector/industry